CD19 and lung cancer: Consistently, GEPIA2 revealed IREB2's negative association with memory B cell markers (MS4A1/CD19/CD27/CD80; Figure S15E). Collectively, memory B cells play crucial roles in COPD‐to‐lung cancer progression, with IREB2 significantly impacting their function.